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The DNA damage response (DDR) triggers widespread changes in gene expression, mediated partly by alterations in
micro(mi) RNA levels, whose nature and signiﬁcance remain uncertain. Here, we report that miR-34a, which is
upregulated during the DDR, modulates the expression of protein phosphatase 1g (PP1g) to regulate cellular tolerance
to DNA damage. Multiple bio-informatic algorithms predict that miR-34a targets the PP1CCC gene encoding PP1g
protein. Ionising radiation (IR) decreases cellular expression of PP1g in a dose-dependent manner. An miR-34a-mimic
reduces cellular PP1g protein. Conversely, an miR-34a inhibitor antagonizes IR-induced decreases in PP1g protein
expression. A wild-type (but not mutant) miR-34a seed match sequence from the 30 untranslated region (UTR) of
PP1CCC when transplanted to a luciferase reporter gene makes it responsive to an miR-34a-mimic. Thus, miR-34a
upregulation during the DDR targets the 30 UTR of PP1CCC to decrease PP1g protein expression. PP1g is known to
antagonize DDR signaling via the ataxia-telangiectasia-mutated (ATM) kinase. Interestingly, we ﬁnd that cells exposed
to DNA damage become more sensitive – in an miR-34a-dependent manner – to a second challenge with damage.
Increased sensitivity to the second challenge is marked by enhanced phosphorylation of ATM and p53, increased
gH2AX formation, and increased cell death. Increased sensitivity can be partly recapitulated by a miR-34a-mimic, or
antagonized by an miR-34a-inhibitor. Thus, our ﬁndings suggest a model in which damage-induced miR-34a induction
reduces PP1g expression and enhances ATM signaling to decrease tolerance to repeated genotoxic challenges. This
mechanism has implications for tumor suppression and the response of cancers to therapeutic radiation.
Introduction
Profound changes in gene expression occur when human cells
are exposed to DNA damage, but their nature, mechanism and
biological significance remain poorly understood. Most attention
has focused on damage-activated transcription factors, including
the tumor suppressor p53 or generic regulators of the transcrip-
tional response to cellular stress including AP-1 or NFkB (eg.1,2)
However, there is emerging evidence that damage-activated
expression of miRNAs also plays a critical role in shaping changes
in gene expression following the exposure of human cells to DNA
damage. miRNAs elicit post-transcriptional gene regulation by
directing the RNA-induced silencing complex (RISC) to a region
on target mRNAs that is complementary to the so-called miRNA
seed sequence spanning nucleotides (nt) 2–7 of the miRNA. The
miR-34 family, comprising miR-34a, b and c, shares the same
seed sequence, and is transcriptionally controlled by p53.3 In par-
ticular, miR-34a (which is the predominant species expressed in
most tissues4) is a major substrate for p53-dependent regula-
tion.3,5,6 Consistent with p53 function, miR-34 family members
act as tumor suppressor miRNAs, by silencing the expression of
several growth-promoting cellular oncogenes, including MET,
CDK6, and E2F to induce G1 arrest, apoptosis or senescence in
different cellular contexts.4 Indeed, miR-34 family members are
de-regulated in several different tumor types.5,7-10 These consid-
erations prompted us to investigate further the potential biologi-
cal role of miR-34a because miR-34a expression is upregulated
during the human DDR in a p53-dependent manner.3,11-13
We report in this work that the enzyme PP1gis targeted by miR-
34a, silencing its expression after DNA damage. PP1g is one of 3
known isoforms of protein phosphatase 1, an important group of
Ser/Thr phosphatases believed to be responsible for the majority of
protein dephosphorylation reactions in eukaryotic cells.14,15 The 3
isoforms appear to be functionally redundant at least in part, since
they share »85% amino acid similarity,16 and genetic ablation of
any single isoform does not cause lethality inmurinemodels.17How-
ever, the regulatory subunits of PP1 family members endow them
with notable functional specificity. Thus, the regulatory subunit of
PP1g – the so-called Repo-man protein.18,19-22 – contributes to spe-
cific roles of the enzyme in several cellular functions, including DNA
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damage checkpoint activation during interphase,18 dephosphoryla-
tion of histone H3T3 during metaphase,20 or in chromatin remodel-
ing and reformation of nuclear envelope at mitotic exit.19
Accordingly, we investigated the functional significance of reduced
PP1g expression by damage-inducedmiR-34a induction.
Interestingly, we find here that chro-
matin-associated PP1g expression
declines after DNA damage to reach its
nadir »72h afterwards, and that at this
time, cells become more sensitive to a
second challenge. Increased sensitivity to
the second round of damage manifests
in evidence that damage-induced signal-
ing via ATM is enhanced, resulting in
enhanced phosphorylation of ATM and
p53, as well as increased gH2AX forma-
tion. Increased sensitivity also manifests
in enhanced cell death induced by the
second DNA damage challenge. These
phenotypes can be partly recapitulated
by a miR-34a-mimic, or antagonized by
an miR-34a-inhibitor. Our findings
therefore suggest a model in which cellu-
lar tolerance to multiple rounds of DNA
damage is modulated via miR-34a-
dependent changes in PP1g expression,
leading to increased ATM signaling.
Such a mechanism may ensure the elim-
ination of damaged cells to suppress
tumor formation after repeated exposure
to genotoxic stress, and also has implica-
tions for the treatment of cancer with
therapeutic radiation.
Results
PP1CCC mRNA encoding PP1g is
predicted to be an miR-34a target
To discern possible functions of
miR-34a induction during the DDR,
we first attempted to identify potential
mRNA targets, using 3 different algo-
rithms that account for various features
of miRNAs and mRNAs into account,
which commonly include thermody-
namic stability of a miRNA::mRNA
duplex, seed region complementarity,
location of a seed region, target site
accessibility, and sequence conservation
among different species. For this
approach, we used 3 different programs:
miRanda,23 picTar4 and picTar5.24 In
brief, miRanda scores miRNA: mRNA
alignment based on sum of the match
values using following base-pair values:
A:U D 5, G:C D 5, G:U D 1, and all other base pairs (mis-
matches) D ¡3.25 picTar4 and picTar5 are 2 different versions
of the same prediction program, which in addition to other fea-
tures account for conservation between 4 (human, mouse, rat,
and dog; picTar4) or 5 (human, mouse, rat, dog, and chicken;
Figure 1. Bioinformatical prediction of miR-34a target genes. (A) Three-way Venn diagram illustrating
the numbers of miR-34a targets predicted by miRanda, picTar4, and picTar5 programs. (B) List of miR-
34a targets predicted by all 3 target prediction programs (*Dtarget that has previously been con-
ﬁrmed as an miR-34a target). (C) Whole sequence of PP1g 30UTR and details of the seed match with
miR-34a. Gray bases indicate the sequence that matches the miR-34a seed. Black lines between bases
represent seed match. Gray line and colon represent base pair and wobble-base pair respectively.
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picTar5) species respectively.26 picTar4
assesses conservation among fewer spe-
cies, but is biased toward identifying pre-
dictions of higher specificity in exchange
for higher sensitivity, due to the inverse
correlation between these factors.42
A total of 22 overlapping targets iden-
tified by all 3 algorithms (Fig. 1A and B)
were considered for further investigation.
The list includes DLL1, a known target
of miR-34a,43 illustrating the feasibility
of the prediction approach. Eight previ-
ously unreognized predicted targets were
confirmed to have miR-34a seed
sequence(s) in their 30UTR using the
TargetScan program (Table S1). Of
these, PP1g, a protein encoded by
PPP1CC, has been previously implicated
in DNA damage checkpoint activation;
it dephosphorylates Ser1981 of pATM
throughout interphase, thereby antago-
nizing ATM-dependent signal transduc-
tion.27 The predicted miR-34a seed
match sequence within PP1g mRNA is
positioned between bases 11–17 of its 30
UTR, with an additional Watson-Crick
base pairing and wobble base pairing
outside the seed match sequence
(Fig. 1C and D).
PP1g mRNA and protein
downregulation accompany damage-
induced miR-34a induction
To address whether PP1g mRNA and
protein downregulation accompany dam-
age-induced miR-34a induction, we stud-
ied their expression in CAL51 cells
exposed to 1, 3 or 9 Gy of IR. RNA pre-
pared from cell extracts harvested every
24 h from 0h – 96 h post-irradiation was
subjected to quantitative reverse-transcrip-
tion polymerase chain reaction (qRT-
PCR) analysis for levels of miR-34a and
PP1g mRNA expression, while a known
miR-34a target, CDK6,28 was studied as
a positive control (Fig. 2B and C). miR-
34a levels exhibited a dose-dependent increase, with maximal
induction to 20.1 fold (SEM D §3.1, n D 3) higher than basal
levels by 72 h after exposure to 9 Gy IR (Fig. 2A). By compari-
son, 1 Gy irradiation induced an 2.7 (§0.3, n D 3) fold increase
in miR-34a expression by 24 h after IR, while 3 Gy induced an
approximately 9.5 (§4.1, n D 3) fold induction by 48 h after IR
(Fig. 2A). Notably, PP1g mRNA expression in the same samples
was inversely correlated with miR-34a induction, reaching a nadir
of »0.2 fold lower than basal expression by 72 h after exposure to
9 Gy IR (Fig. 2B). A lower dose of 1 Gy IR had little measurable
effect on PP1g mRNA expression, consistent with markedly lower
induction of miR-34a at the same dose. CDK6 mRNA levels also
decreased after IR, albeit less sharply than observed with PP1g
mRNA (Fig. 2B).
Next, we used Western blotting to determine PP1g or CDK6
protein expression in extracts prepared from the same samples,
using antibodies that specifically recognize each of the proteins
(Fig. S1A). PP1g protein expression was little affected after 1 Gy
IR, but was decreased with 3 Gy and 9 Gy in a dose-dependent
manner from the 72 h timepoint (Fig. 2C). Reduced CDK6
Figure 2. Dose-dependent miR-34a induction after IR is accompanied by down-regulation of PP1g
mRNA and protein. (A) Cal51 cells were irradiated with 1, 3 and 9 Gy and were harvested every 24 h
up to 96 h. The 0 h sample not exposed to IR was deemed as a negative control. miR-34a expression
was studied by qRT-PCR (n D 3; §SEM). (B) PP1g and CDK6 mRNA expression was studied by qRT-
PCR (n D 3; §SEM). (C) Western blot analysis. Numbers shown below PP1g, PP1a and PP1b blots are
densitometry values representing relative protein expression.
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protein expression occurred somewhat earlier (Fig. 2C), and did
not closely mirror reductions in mRNA levels (Fig. 2B), raising
the possibility that miR-34a may act at a later stage during gene
expression to affect CDK6 mRNA translation, as reported for
other miR species.29 In contrast, PP1a
and b protein levels showed little varia-
tion after IR (Fig. 2C), suggesting that
this response is specific to PP1g.
Consistent with previous reports,3,11-13
we find that damage-induced miR-34a
induction depends on p53 (Fig. S2). In
Cal51 cells, depletion of p53 using short
interfering (si)RNAs decreases by>3-fold
the induction of miR-34a expression at
72h after exposure to 3 Gy IR. Moreover,
it has been reported that neuronal differen-
tiation and synaptic outgrowth are regu-
lated via the p73-mediated regulation of
miR-34a in neuronal cells,30,31 raising the
possibility that p73 or p63may also partic-
ipate in miR-34a regulation after DNA
damage. However, we have been unable to
directly test this possibility owing to tech-
nical difficulties in achieving efficient and
selective depletion of different p63 and
p73 isoforms in our experimental setting.
An miR-34a mimic reduces PP1g
protein expression
We transfected a mimic of miR-34a
into CAL51 cells to determine effects on
PP1g expression. Analysis of the trans-
fected cells by qRT-PCR and western
blot revealed that the overexpression of
miR-34a mimic suppresses PP1g expres-
sion at both mRNA and protein level
(Fig. 3A, B, and Fig. S1B, C). Decreased
PP1gmRNA expression reaches its nadir
about 48 h after miR-34a mimic trans-
fection, and remains at this level (Fig.
S3B and C). However, the magnitude of
protein downregulation (»60%) was
somewhat higher than that of mRNA
(»35%), raising the possibility that the
miR-34a-mimic may in part regulate
PP1g expression at the translational
level. These findings confirm that PP1g
mRNA and protein are indeed reduced
by an miR-34a mimic, consistent with
the notion that their expression is tar-
geted by this miR species.
An miR-34a inhibitor counteracts
the damage-induced reduction in PP1g
protein expression
To confirm that miR-34a induc-
tion after DNA damage is responsible for the observed
decrease in PP1g expression, we asked if an inhibitor of
miR-34a could counteract this effect. We transfected CAL51
cells with miR-34a inhibitor before exposure to 9 Gy IR, the
Figure 3. PP1g is a target of miR-34a. (A) Cal51 cells were transfected with 50 nM miR-34a mimic or
Luc siRNA and harvested 72 h post-transfection for analysis. qRT-PCR of PP1g and CDK6 was per-
formed (one-way ANOVA with Dunett’s post-test; *P < 0.05) (n D 4; §SEM). (B) Western blot analysis.
The densitometry graph was generated from 4 independent experiments. (2-way ANOVA with Bonfer-
roni’s post-test; ***P < 0.001) (n D 4; §SEM). (C) Experimental scheme. Cal51 cells were irradiated with
9 Gy, 5 h after transfection with miR-34a inhibitor or Luc siRNA. The cells were analyzed 72 h post-
transfection. (D) qRT-PCR of PP1g and CDK6 mRNA expression. The plotted values show the mean
§SEM (one-way ANOVA with Dunett’s post-test; **P < 0.01, ***P 0.001, respectively) (n D 4). (E)
Western blot analysis of the miR-34a inhibitor experiment. The densitometry graph shows the mean
§SEM of 3 independent experiments. The values of the samples were ﬁrst normalized to b-actin, and
then subsequently normalized to 0 Gy Luc siRNA transfected samples (2-way ANOVA with Bonferroni’s
post-test; *P < 0.05) (n D 3). (F) Schematic showing psiCHECK2-PP1g_30UTR constructs with either the
wild-type (WT) or mutant (mt) forms of the predicted miR-34a seed match sequence in the PP1g
30UTR. Black lines between bases represent seed match. Gray line and colon represent base pair and
wobble-base pair respectively. Bases in gray represent mutations introduced to disrupt matches
between miR-34a and PP1g. (G) Cal51 cells were co-transfected with psiCHECK2-PP1g_30UTR WT or
mt and negative control miRNA or miR-34a mimic. Fluorescence was measured 72 h post-transfection.
Reporter Renilla ﬂuorescence values were normalized to Fireﬂy luciferase ﬂuorescence encoded in the
same plasmid. Plots show the mean §SEM (2 tailed t-test with Bonferroni’s post-test; **P 0.01) (n D 4).
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dose at which the highest downregula-
tion of PP1g is observed at 72–96 h
after exposure (Fig. 2B). Extracts pre-
pared from miR-34a inhibitor-treated
cells 72 h after IR exposure were sub-
jected to qRT-PCR and Western blot
analysis (Fig. 3C). Damage-induced
decreases in PP1g mRNA and protein
expression were counteracted in part
by the miR-34a inhibitor (Fig. 3D
and E). For PP1g protein, treatment
with the miR-34a inhibitor caused an
approximately 2-fold increase in
expression, to about half the level of
basal expression.
Transplantation of wild-type and
mutant miR-34a seed match sequences
to a luciferase reporter gene
Our results thus far show that
DNA damage-induced upregulation of
miR-34a is accompanied by decreased
PP1g expression (Fig. 2B and C),
that the overexpression of an miR-34a
mimic suppresses PP1gexpression
(Fig. 3A and B), and that an miR-
34a inhibitor partially counteracts
damage-induced reductions in PP1g
mRNA and protein expression
(Fig. 4C–E). Together, these results
provide strong evidence that damage-
induced miR-34a upregulation silen-
ces PP1g expression. To further vali-
date this conclusion, we tested
whether the miR-34a seed match
sequence from the 30 UTR of PP1g
mRNA could make a heterologous
luciferase reporter gene become miR-
34a responsive. To this end, we inserted either wild-type
(WT) or mutant forms of the miR-34a seed match sequence
the 30UTR of PP1g downstream of the Renilla luciferase
gene. The seed match sequence and some complementary
bases outside the seed match sequence were mutated to gener-
ate a mutant plasmid (Fig. 3F). The luminescence of miR-
34a mimic or negative control miRNA transfected cells co-
transfected with the predicted seed match sequence WT or
mutant plasmid was then measured. Approximately 30%
lower Renilla luciferase activity was detected in the samples
co-transfected with WT plasmid and miR-34a mimic, com-
pared to the samples co-transfected with WT plasmid and
negative control miRNA (Fig. 3G). By contrast, there was no
significant difference in Renilla luciferase activity between the
samples co-transfected with mutant plasmid and miR-34a
mimic or negative control miRNA, confirming that miR-34a
directly targets PP1g through PP1g 30UTR seed match
sequence (Fig. 3G).
Damage-induced reduction in PP1g via miR-34a enhances
ATM signaling
These observations led us to consider the potential biological
significance of miR-34a-induced reductions in PP1 expression
after DNA damage. PP1g is directed onto chromatin upon ana-
phase onset by its regulatory subunit Repo-man, forming a
PP1g-Repo-man holoenzyme.27 The holoenzyme dephosphory-
lates ATM throughout interphase (Fig. 4A), suppressing down-
stream signal transduction,27 and is dispersed into the cytoplasm
at the beginning of prophase.22,44 This function appears to be
specific to PP1g, because it is the only one of the 3 PP1 isoforms
that is localized to chromatin via Repo-man.27
The localization of PP1g protein to chromatin, nucleus and
cytoplasm led us to ascertain whether miR-34a-dependent reduc-
tions in expression affected both compartments. We therefore
prepared extracts from the corresponding compartments in
CAL51 cells exposed to miR-34a-mimic, or control RNA, for
72 h before protein gel blotting with an antibody against PP1g.
Figure 4. Decreased PP1g protein expression in different cellular fractions after IR. (A) Schematic
depiction of the PP1g. ATM interaction. PP1g bound to its regulatory subunit Repo-man is proposed
to inhibit ATM phosphorylation and activation via colocation on chromatin. (B) Cytoplasmic, nucleo-
plasmic, and chromatin protein fractions from Cal51 cells were prepared 72 h after transfection with
either Luc siRNA or miR-34a mimic, and the PP1g protein level was determined by western blotting.
(C) The densitometry graph shows relative PP1g protein expression in each lane normalized to the
corresponding loading control. Plots show the mean §SEM (2-way ANOVA with Bonferroni’s post-
test, *P < 0.05) (n D 3).
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PP1g is expressed in all of the subcellular
fractions studied (Fig. 4B and C). The
highest expression was observed in the
chromatin fraction (»60% of the total
cellular PP1g) while the cytoplasmic frac-
tion had the lowest expression (»10% of
total protein). Exposure to the miR-34a
mimic suppressed PP1g by about 2-fold
on chromatin and by about 1.6-fold in
the cytoplasm, relative to their corre-
sponding negative control siRNA trans-
fected samples, normalized to a
designated subcellular marker (Fig. 4B
and C). These results suggest that miR-
34a reduces PP1g protein expression in
all subcellular compartments.
We find that miR-34a induction after
IR rises 24–48 h after exposure to reach
its peak by about 72–96 h (Fig. 2A).
Thus, miR-34a induction is not an
immediate or early response to DNA
damage, and so its effect on PP1g expres-
sion is not expected to affect DNA dam-
age signaling via ATM after a first
exposure, because ATM-mediated events
initiate within minutes.32 This led us to
ask whether the ATM response might be
impaired 72 h after the exposure of cells
to miR-34a mimic, when PP1g expres-
sion reaches its nadir.
We first chose to investigate the
effect of miR-34a-mimic on the forma-
tion of gH2AX, a phosphorylated
form of the variant histone H2AX,
which is directly modified by ATM
within minutes of DNA damage, and
serves as a well-established marker for
downstream signaling via the ATM
pathway.33 Damage was administered
with IR, which induces DNA breaks
that predominantly activate ATM
rather than other related enzymes like
ATM and Rad53-related kinase,
ATR.34 Accordingly, CAL51 cells
Figure 5. PP1g protein downregulation by
miR-34a mimic sensitizes cells to DNA dam-
age. (A) Experimental scheme. At 72 h after
transfection with Luc siRNA, miR-34a mimic
or PP1g siRNA, Cal51 cells were irradiated
with 1, 3 or 9 Gy, and harvested 30 mins
post-IR for analysis. (B–D) Analysis by West-
ern blot after IR exposure of PP1 isoform
expression, PP1g in different cellular frac-
tions, and gH2AX expression.
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exposed to miR-34a-mimic were incubated for 72 h to allow
PP1g suppression, before exposure to 1, 3 or 9 Gy IR, and
assessment of gH2AX formation 30 min afterwards (Fig. 5A).
Cell lysates were subjected to Western blot analysis. PP1g
protein expression is downregulated by exposure to the miR-
34a mimic (as well as with PP1g siRNA used as a positive
control) (Fig. 5B). Levels of PP1a or PP1b were not greatly
affected. Moreover, fractionation of cell extracts exposed to 3
Gy IR showed a downregulation of chromatin-localized
PP1g, as well as PP1g in nucleoplasmic and cytoplasmic
compartments, in both miR-34a mimic and PP1g siRNA
transfected samples (Fig. 5C). There was no significant effect
of miR-34a mimic or PP1g siRNA on cell cycle distribution
analyzed by flow cytometry (data not shown). Notably, both
miR-34a mimic or PP1g siRNA transfected samples exhibited
a higher gH2AX level than controls exposed to 1 or 3 Gy
(Fig. 5D), indicating that ATM signaling had indeed been
enhanced via PP1g suppression.
Damage-induced miR-34a induction enhances ATM
signaling to a second challenge via PP1g suppression
These observations led us to ask whether damage-induced
decreases in PP1g expression mediated by miR-34a might
affect ATM signaling in cells exposed to a second challenge
with DNA damage, administered 72 h after the first expo-
sure, to coincide with the peak effects of miR-34a induction
on PP1g expression. To address this issue, we transfected
CAL51 cells with miR-34a inhibitor or negative control
siRNA, then irradiated the cells with 3 Gy approximately 5 h
post-transfection to induce miR-34a. After incubating the
cells for 72 h post-3 Gy IR, they were irradiated again with
1, 3, or 9 Gy IR, with cells not exposed to IR (IR-) deemed
as the negative control (Fig. 6A). The cells were incubated
for 30 min after the second round of irradiation the prepara-
tion of cell extracts for Western blot analyses. There was no
significant difference in the cell cycle profile between different
samples exposed to 3 Gy IR (data not shown). Importantly,
samples transfected with miR-34a inhibitor exhibited
decreased ATM signaling after 1 or 3 Gy IR, marked by
decreases in gH2AX formation, and the appearance of the
ATM pSer1981 activation marker,35 when compared to sam-
ples transfected with negative control siRNA (Fig. 6B).
Unlike gH2AX, the difference in pATM level was evident
even in the unirradiated negative control samples, suggesting
that some pATM activity might be carried over from the first
round of irradiation. We also studied the phosphorylation of
another ATM target, p-p53 Ser15. Although total p53
expression is not altered after a second challenge with IR, the
levels of p-p53 Ser15 exhibited a dose-dependent increase in
samples transfected with negative control siRNA transfected
samples (Fig. 6B). However, p-p53 Ser 15 expression was
decreased in samples transfected with miR-34a, again illus-
trating that ATM signaling is enhanced by damage-induced
miR-34a, a delayed response to DNA damage that can be
counteracted by the miR-34a inhibitor (Fig. 6B).
Damage-induced miR-34a induction enhances cell death
after a second challenge
Next, we carried out a colony formation assay (CFA), which
identifies the post-irradiation survival of cells which have retained
the capacity to give rise to a progeny of at least 50 cells.36 The
experiment was carried out as before, but cells were replated after
the second challenge with IR at a low density in 6-well plates to
allow the formation of colonies. The plates were incubated until
the colonies were visible but not confluent, before staining with
crystal violet dye for quantification (Fig. 7A). Results are plotted
in the graph, which shows the surviving fraction as a ratio of the
colony number in experimental samples normalized to unirradi-
ated controls. Our findings (Fig. 7B and C) shows that cell sur-
vival after the second challenge with IR is reduced when cells are
transfected with either the miR-34a-mimic, or with PP1g siRNA,
both of which we have shown to reduce PP1g protein expression.
This effect is statistically significant when cells are exposed to 9
Gy IR in the second challenge, but not at lower doses. Moreover,
a similar experiment in which cells have been transfected with
miR-34a inhibitor (Fig. 8A), which we have shown to counteract
radiation-induced reductions in PP1g protein expression, increases
cell survival after the second IR challenge (Fig. 8B and C). Again,
the difference is statistically significant at 9 Gy but not at lower
doses. These findings suggest that damage-induced miR-34a
induction enhances cell death after a second challenge with IR,
consistent with its observed effects on ATM signaling.
Figure 6. An miR-34a inhibitor counteracts PP1g protein downregulation
and increased ATM signaling after a second challenge with DNA dam-
age. (A) Experimental scheme. Cal51 cells transfected with Luc siRNA or
miR-34a inhibitor were irradiated with 3 Gy at 5 h post-transfection. A
second challenge with irradiation (1, 3 or 9 Gy) was given at 72 h post-
transfection. The cells were harvested for analysis 30 min after the sec-
ond IR challenge. (B) Analysis by Western blot of markers of ATM signal-
ing (pATM Ser1981, phospho-p53 Ser15, gH2AX) and PP1g expression
after a second challenge with IR in cells exposed to Luc siRNA or miR-34a
inhibitor.
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Discussion
Our findings suggest a novel biological role for miR-34a
induction following DNA damage. We propose (Fig. 9) that
miR-34a induction, which reaches a peak some 72 h after induc-
tion, increases the sensitivity of cells to a second challenge with
DNA damage, by decreasing the expression of PP1g protein and
thereby enhancing signaling via the damage-responsive ATM
kinase. Our proposal has several noteworthy implications.
First, it reveals a previously unrecognized mechanism by
which the changes in miRNA expression that have recently been
shown to occur after DNA damage can influence the biological
response to these lesions. Indeed, expression of the miR-99 fam-
ily has been previously shown to radiosensitize cells through the
downregulation of SNF2H, a facilitator of DNA double-strand
break repair,37 suggesting that damage-induced miRNAs may
orchestrate a complex network of alterations in the expression of
proteins that participate in the DNA damage response. Cell-type
specificity in the patterns of damage-induced miRNA expression
is noteworthy in this context13; while miR-99 expression is
apparently restricted in its tissue distribution, miR-34a is widely
expressed in a p53-dependent manner.38
Second, our results suggest a biologi-
cal significance for the kinetics of
damage-induced miRNA expression.
Whereas immediate events that lead to
the sensing, signaling and repair of DNA
damage begin within minutes,32 dam-
age-induced changes in miRNA expres-
sion typically reach their peak many
hours (24–72 h) after these immediate
events. We provide several lines of evi-
dence that miR-34a-induced changes in
PP1g protein expression some 72 h after
damage can sensitize cells to a second
challenge with damage, via the enhance-
ment of ATM signaling. We speculate
that such a response may “pre-arm” cells
exposed to sub-lethal amounts of damage
to subsequent, repeated challenges; “pre-
arming” may be particularly important
in metazoan organisms to preserve fitness
through the elimination of damaged cells
that might trigger carcinogenesis follow-
ing repeated exposure to genotoxic
stimuli.
Conversely, we speculate that miR-
34a-induced “pre-arming” may render
cancer cells more sensitive to fraction-
ated therapeutic radiation (which is
administered in multiple small doses
over a period of time). Fractionated
radiotherapy is more efficacious than
single-dose therapy, but the mecha-
nism underlying this remains unclear,
although several factors have been
implicated.37 If so, our work suggests that the integrity of the
p53 pathway, which is reported to be necessary for damage-
induced miR-34a induction,39 may be essential. Thus, the
new mechanism that we report in this work has clinical
implications for cancer radiotherapy that warrant further
investigation. In vivo investigation of this notion using
siRNA is warranted, but technically challenging owing to the
difficulties in prolonged suppression of target expression with
this approach,40 and so alternative approaches may be
required.
Materials & Methods
Cell lines
CAL51 (human basal B subtype breast cancer cell line) was
cultured in Dulbecco’s Modified Eagle’s Medium with Gluta-
MAXTM-1, 4500 mg/L D-glucose, sodium pyruvate and pyri-
doxine (Life Technologies), supplemented with 10% fetal bovine
serum (Life Technologies) and 100 units/ml penicillin-strepto-
mycin (Life Technologies). The cells were maintained in a
humidified incubator at 37C under 5% CO2.
Figure 7. PP1 depletion using siRNA or an miR-34a mimic decreases clonogenic cell survival after
DNA damage. (A) Experimental scheme. Cal51 cells were transfected with Luc siRNA, miR-34a mimic
or PP1g siRNA. Cells were replated into 6-well plates at 48 h post-transfection. At 72 h post-transfec-
tion, the plates were irradiated (1, 3, or 9 Gy), incubated for further~10 days and subjected to crystal
violet staining once they reached their optimal density. The colonies were then counted and ana-
lyzed. (B) Survival curves from a representative experiment (§SD). (C) Survival fraction values of each
experimental sample were normalized to those from the corresponding Luc siRNA transfected sam-
ples exposed to the same IR dose (2-way ANOVA with Bonferroni’s post-test; ***P < 0.001) (mean §
SEM; n D 2).
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X-ray irradiation
X-ray irradiation was performed by
exposing cultured cells to irradiation
using Faxitron RX-650 (Faxitron Bio-
ptics; irradiation dose rates of 0.492,
0.358, and 0.211 Gy/min) at 120 kVp at
5 mA at room temperature.
Transient transfection
Cells were transfected with plasmid
and siRNA or miRNA mimic/inhibitor
using Lipofectamine 2000TM (Life Tech-
nologies) and Dharmafect I (Life Tech-
nologies) respectively, following
manufacturer’s instructions. The details
of siRNA and miRNA mimic/inhibitor
are provided in supplementary table.
Western blotting
The harvested cells were washed in
PBS and lysed in NP-40 buffer (50 mM
HEPES pH 7.4, 100 mM NaCl, 0.5%
NP-40, 10 mM EDTA, 20 mM b-Glyc-
erophosphate, supplemented with 1 mM
DTT, 1 mM PMSF and 1 x protease
inhibitor (Amersham)). The cells were
incubated on ice for 15 min. Lower con-
centration of EDTA (1 mM) was used
instead of 10 mM EDTA when Benzo-
nase Nuclease (Millipore) was added, as
high concentration of EDTA inhibits its
enzymatic activity. Benzonase Nuclease
was supplemented at a concentration of
25 U/ml, and the cells were incubated on ice for 30 min to facili-
tate the reaction. The samples were centrifuged at 12,000 g for
15 min at 4C. The supernatants were retained, placed on ice
and subjected to protein quantification using Bicinchoninic
Assay (BCA) (Sigma). An equal amount of protein was subjected
to analysis. 4 x lithium dodecyl sulfate (LDS) loading buffer (Life
Technologies) was diluted to 1 x and supplemented with
100 mM DTT. The buffer was mixed with the whole cell lysate
and was denatured at 70C for 10 min. Alternatively, the cells
were sonicated in NP-40 buffer. Samples were resolved by pre-
cast gels (Life Technologies). Protein was transferred to an acti-
vated Immobilon-P membrane (Millipore) or nitrocellulose
membrane (Sigma), either wet or semi-dry. The membrane was
blocked either with 5% non-fat milk or 3% BSA in TBS-Tween
on a rocker for 30–60 min at room temperature. The membrane
was then incubated with primary antibody diluted in either 5%
milk or 3% BSA in TBS-Tween. The membrane was incubated
for overnight at 4C or 4 h at room temperature. After primary
antibody incubation, the membrane was placed on an orbital
shaker and washed in TBS-Tween for 3 £ 5 min. The mem-
brane was incubated with secondary antibody diluted at a ratio of
1:10,000 in either 5% milk or 3% BSA in TBS-Tween on an
orbital shaker for 1 h at room temperature. Then, the membrane
was again washed in TBS-Tween for 3 £ 5 min. The protein of
interest was detected by applying ECL or ECL plus (GE health-
care) following manufacturer’s instructions. The membrane was
wrapped with Saran and exposed to CL-XPosure Film (Thermo
Scientific) for an appropriate amount of time to detect the pro-
tein of interest.
b-Actin was deemed as a loading control for whole cell west-
ern blot; Mek2 and Rad21 were deemed as a loading control for
cytoplasmic and chromatin fraction protein gel blot respectively,
unless otherwise stated.
Cellular fractionation assay
Cellular fractionation assay was performed as previously
described.41 Briefly, the harvested cells were washed in PBS. The
cell pellet was resuspended in 1 ml of buffer A (10 mM HEPES
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10%
glycerol, 1 mM DTT, 1 mM PMSF, 1 x protease inhibitors,
5 mM NaV, 10 mM NaF and 1 uM Okadaic acid, diluted in
dH2O) per 4 £ 107 cells, and 0.05% Triton X-100 was added.
The sample was aspirated and dispensed gently to mix. Nuclei
were collected by centrifuging at 1300 g for 4 min at 4C.
Supernatant (cytoplasmic fraction), was transferred to a fresh
tube and clarified by centrifuging at 20,000 g for 15 min at 4C.
Figure 8. An miR-34a inhibitor counteracts decreased clonogenic cell survival after a second chal-
lenge with DNA damage. (A) Experimental scheme. Cal51 cells were transfected with Luc siRNA or
miR-34a inhibitor and were irradiated with 3 Gy 5 h post-transfection. Cells were replated into 6-well
plates at 48 h post-transfection. At 72 h post-transfection, the plates were irradiated for a second
time (with 1, 3, or 9 Gy), and then incubated for further~10 days and subjected to crystal violet stain-
ing once they reached optimal density. The colonies were then counted and analyzed. (B) Survival
curves of a representative experiment (§SD). (C) Survival fraction values of miR-34a inhibitor trans-
fected samples were normalized to those from the corresponding Luc siRNA transfected samples
exposed to the same IR dose (2-way ANOVA with Bonferroni’s post-test; ***P < 0.001) (mean § SEM;
n D 3).
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The nuclear pellet was washed in half the volume of buffer A used
for the initial resuspension to remove cell debris and insoluble
aggregates. The washed nuclear pellet was lysed in buffer B
(3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, 1 mM PMSF, 1
x protease inhibitor, 5 mM NaV, 10 mM NaF and 1 uM Oka-
daic acid, diluted in H2O) (0.8 volume of buffer A used for the
initial resuspension) by aspirating and dispensing gently. It was
then centrifuged at 1700 g for 4 min at 4C to pellet chromatin,
and its supernatant (nuclear fraction), was transferred to a fresh
tube. Chromatin pellet was resuspended in half the volume of
buffer A used for the initial resuspension, adjusted with 1 mM
CaCl2 and 0.2 U micrococcal nuclease. It was incubated at 37
C
for 5–10 min, EGTA was added to 1 mM to quench the reac-
tion, and was centrifuged at 20,000 g for 10 min at 4C to col-
lect supernatant (chromatin fraction). Cytoplasmic, nuclear, and
chromatin fractions were quantitated by BCA.
Antibodies
The antibodies in Table 1 were used in the experiments car-
ried out.
Densitometry
Scanned blot was analyzed by Image J (National Institutes of
Health). The densitometric values for protein of interest were cal-
culated and normalized to their loading control.
RNA extraction and reverse transcription
TRIzol Reagent (Life Technologies) was used to extract total
RNA following manufacturer’s instructions. The extracted RNA
was polyadenylated by mixing 1–10ug of RNA diluted up to
20 ml in RNase free water, 6 ml of 5 x First-Strand Buffer (Life
Technologies), 3 ml of 10 mM adenosine triphosphate (ATP)
(New England Biolabs), and 1 ml of E. coli poly (A) polymerase
(New England Biolabs) and incubating at 37C for 60 min fol-
lowed by 65C incubation for 20 min. The same amount of
RNA was used for all samples within the same experiment. For
reverse transcription, 1 ml of Oligo (dT) adapter (0.25 mg/ml),
3 ml of Random Hexamers (0.4 mg/ml) (Promega), 1 ml of
10 mM dNTP mix (Life Technologies), 2 ml of 5 x First-Strand
Buffer (Life Technologies), 2 ml of 0.1 M DTT, and 1 ml of
Super Script II reverse transcriptase (Life Technologies) were
mixed together. The mixture and 30 ml of the polyadenylated
RNA solution were mixed together and incubated for 50 min at
42C, followed by 70C incubation for 10 min. The following
Oligo (dT) adapter primer was used in the reaction:
50GCGAGCACAGAATTAATACGACTCACTATAGGTTTT
TTTTTTTTVN30
qRT-PCR
PCR mix: cDNA, 0.5 uM of forward and reverse primers and
SYBR Green I master mix (Roche) was plated on LightCycler
480 Multiwell Plate 96 (Roche). All reactions were carried out in
triplicates, and the same amount of cDNA was used for all sam-
ples in the same experiment. Triplicate wells without cDNA
were prepared per plate as a no template control. Internal control
was studied per plate, which were GAPDH and U6 snRNA, for
mRNA and miRNA respectively. The plates were sealed by a
Figure 9. miR-34a regulates DNA damage tolerance by targeting PP1g.
The ﬁgure illustrates the model suggested by our ﬁndings wherein the
induction of miR-34a expression by DNA damage acts via PP1g to
decrease the threshold for damage signaling via ATM. Immediate events
at the site of damage lead to DNA damage repair. The induction of miR-
34a and consequent downregulation of PP1g, peaking some 72 h after
exposure to damage, is a late event that alters cellular tolerance to
increase sensitivity to a second challenge with DNA damage.
Table 1. Antibodies used in this paper.
Antibody Supplier Western dilution
b-Actin Sigma Aldrich 1 in 3000
CDK6 Santa Cruz 1 in 200
gH2AX (Ser139) Cell Signaling 1 in 1000
Lamin a/c Santa Cruz 1 in 500
MEK2 BD Biosciences 1 in 3000
PP1a Bethyl Laboratory 1 in 1000
PP1b Bethyl Laboratory 1 in 1000
PP1g Santa Cruz 1 in 200
p53 Oncogene 1 in 500
pATM (Ser1981) Epitomics 1 in 500
p-p53 (Ser15) Cell Signaling 1 in 500
Rad21 (SCC1) abcam 1 in 1000
Rb Santa Cruz 1 in 200
p73 Santa Cruz 1 in 100
p63 abcam 1 in 1000
p63(TA) bioLegend 1 in 1000
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sealing foil (Roche), and were loaded on to LightCycler 480
instrument (Roche). The pre-programmed PCR protocol on
LightCycler 480 instrument specific for SYBR Green I Master
using a LightCycler 480 Multiwell Plate 96 was used. Compara-
tive Ct method was used to quantify the expression of mRNA
and miRNA of interest. The details of primers used are provided
in supplementary table.
Plasmid construct
PP1g 30UTR was amplified from genomic DNA (gDNA)
extracted from CAL51 using DNAzol (Life Technologies) fol-
lowing manufacture’s instructions. Construct was generated by
sub-cloning PP1g 30UTR into XhoI (50) and NotI (30) restriction
sites of psiCHECK2 plasmid using T4 Ligase (New England
Biolabs). Mutant plasmid was produced by site-directed muta-
genesis through running PCR reactions using forward and reverse
primer with the desired mutations using the Quik-Change Site-
Direct Mutagenesis kit (Stratagene).The insert identity was vali-
dated by sequencing. The primers used for mutagenesis were:
sense, 50GCGATCGCTCGAGATGTCATCTTCGAGGCTAG
TAGTCG30 antisense, 50CGACTACTAGCCTCGAAGATGA
CATCTCGAGCGATCGC30 (the mutated nucleotides are
underlined and italicized).
30UTR luciferase reporter assay
psiCHECK2-PP1g 30UTR WT or mt and miR-34a or nega-
tive control miRNA were transfected into CAL51 cells with Lip-
ofectamine 2000TM. The transfected cells ready for analysis were
replated into 12-well plate at least one day before the assay.
Luminescent signal was measured using Dual-Glo Reagent
(Promega) following manufacturer’s instructions. The lumines-
cence measurement was taken by Luminometer (BMG LAB-
TECH). The data was analyzed by calculating the ratio of
luminescence from the experimental Renilla reporter to lumines-
cence from the control Firefly reporter. The ratio was normalized
to the ratio of control samples.
Colony formation assay
Colony formation assay was performed as previously
described.36 Briefly, cells were plated at an optimal concentration
for colonies to form. The plates were incubated until they reach
the optimal concentration. To stain the colonies with crystal vio-
let, the plates were first washed PBS. The cells were then fixated
with 4% formaldehyde for 20 min at room temperature. Fixative
was removed from the wells, washed once with water, and the
plates were dried. 0.1% crystal violet (Sigma-Aldrich) was dis-
pensed to the dried wells, incubated for 20 min, then the crystal
violet solution was removed and the plates were washed with
water for 3 times. The plates were dried and the colonies were
counted and analyzed.
Statistical analysis
All statistical analysis was performed using Graph Pad Prism
version 5.00 software (Graph Pad Software, Inc.).
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